RxToolKit and NeuroNet Pro Announce Partnership to Improve Clinical Education and Safety for Neurology Practices

12 April 2023 | Wednesday | News

RxToolKit, a provider of clinical education and infusion safety software, and NeuroNet Pro, an organization dedicated to supporting the long-term success and advancement of neurology practices, have partnered to advance safety and training protocols for neurology treatments.
Image Source : Public Domain

Image Source : Public Domain

This collaboration extends preferred pricing on RxToolKit's software solutions in addition to other exclusive benefits already available to NeuroNet Pro members.

 

"Our team is dedicated to supplying clinical services and opportunities that improve service quality and promote the sustainability of neurology practices," said Texas Neurology CEO and NeuroNet Co-Founder David Evans. "This partnership with RxToolKit will provide a progressive error-prevention and training management solution for our neurology members, as well as the multitude of benefits already available via membership."

The RxToolKit software houses a digital library of drug-specific monographs and corresponding training courses commonly used in the treatment of neurological disorders. The collaboration will introduce RxToolKit's modern infusion safety solution to NeuroNet members and furthers NeuroNet Pro's mission of bringing value-based solutions to the field of neurology.

"We are thrilled about our partnership with the NeuroNet team and the opportunity to advance safety and education in neurology infusion suites across the country," said RxToolKit CEO Bryan Johnson. "RxToolKit's mission is to promote the education and wellbeing of patients and clinicians in order to create a safe, clinically competent infusion industry. This collaboration will not only support current RxToolKit neurology clients, but nurture our mission for safety process improvements."

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close